United States · FDA National Drug Code directory
Baqsimi
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0548-8352_8d3aa4dd-737c-49b4-af0d-fe95e3bee54d
- Product NDC
- 0548-8352
- Form
- POWDER
- Composition / generic term
- glucagon
- Labeler
- Amphastar Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190724
- Source listing expiry
- 20261231
Source-listed ingredients
- GLUCAGON — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TUBE in 1 CARTON (0548-8352-02) / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSE · 0548-8352-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →